N37: Fatigue in Japanese patients with Inflammatory Bowel Disease: a comparative study based on a systematic reviewECCO'24Year: 2024
Authors: Takai, M.(1);Tanaka, M.(2)*;Sakagami, K.(3);Ito, H.(3);
(1)Tokyo Medical and Dental University TMDU, Adult Health Nursing, Tokyo, Japan;(2)Tokyo Medical and Dental University TMDU- Graduate School of Health Care Sciences-, Dep. Adult Health Nursing, Tokyo, Japan;(3)Kinshukai Infusion Clinic, Gastroenterology, Osaka, Japan;
N38: Male patients with Crohn@E@s Disease and perianal fistulae and their experience of sexuality and dialogue with healthcare professionals about their sexuality - a qualitative interview study.ECCO'24Year: 2024
Authors: Winther Andersen, K.(1)*;Primdahl , J.(2,3,4);
(1)Department of Gastroenterology, Lillebaelt Hospital, Vejle, Denmark;(2)University Hospital of Southern Denmark, Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark;(3)University of Southern Denmark, Department of Regional Health Research, Odense, Denmark;(4)University Hospital of Southern Denmark, Hospital Sønderjylland, Aabenraa, Denmark;Joan Lysholdt Sara Emmerich Jensen Malene Ottsen Conrad Helle Grønlund Tina Holte Köllner Anne Louise Brix Nørgaard Tenna Rydder Hansen Annette Østerkjærhus
N40: Surveying outcomes of service user experience on the effects of the transition process in paediatric IBD (PIBD) patients in a tertiary PIBD centreECCO'24Year: 2024
Authors: Buckingham, R.(1)*;Chadokufa, S.(1);Lashley, C.(1);Huggett, B.(1);Sawney, T.(1);Kiparissi , F.(1);Elzien , A.(1);
(1)Great ormond street hospital, IBD, London, United Kingdom;Catherine Lashley Sibongile Chadokufa Bonita Huggett Terry Sawney Fevronia Kiparissi Aya Elzein
N44: Implementing Electronic Documentation of a Nurse-Led IBD Advice LineECCO'24Year: 2024
Authors: Lukose, T.(1)*;Lardner , C.(2);O Toole , A.(2);Boland , K.(2);
(1)Beaumont Hospital, Inflammatory Bowel Disease, Dublin, Ireland;(2)Beaumont Hospital, Inflammatory Bowel Disease, Dublin 9, Ireland;
N46: Stress after an Ulcerative Colitis diagnosis: examining the role of psychological factors in Ulcerative Colitis using Interpretative Phenomenological AnalysisECCO'24Year: 2024
Authors: Black, J.(1)*;Norton, C.(2);Sweeney, L.(2);Czuber-Dochan, W.(2);
(1)King@E@s College London, Florence Nightingale Faculty of Nursing- Midwifery & Palliative Care, London, United Kingdom;(2)King@E@s College London, Florence Nightingale Faculty of Nursing- Midwifery- and Palliative Care, London, United Kingdom;
N47: Spiritual needs of patients with IBD: preliminary results of a pilot studyECCO'24Year: 2024
Authors: Starnella, G.(1);Rosato, I.(1);Canova, C.(1);Savarino, E.V.(2);Zingone, F.(2);Barberio, B.(2);Lorenzon, G.(2);Gregori, D.(1);Comoretto, R.I.(3);MartinatoRN PhD, M.(1)*;
(1)Unit of Biostatistics- Epidemiology and Public Health- University of Padova, Department of Cardiac- Thoracic- Vascular Sciences and Public Health, Padova, Italy;(2)Gastroenterology Unit- University of Padova, Department of Surgery- Oncology and Gastroenterology, Padova, Italy;(3)University of Torino, Department of Sciences of Public Health and Pediatrics, Torino, Italy;
OP01: PROFILE: a multi-centre, randomised, open-label, biomarker-stratified clinical trial of treatment strategies for patients with newly-diagnosed Crohn’s diseaseECCO'24Year: 2024
Authors: Noor, N.(1,2)*;Lee, J.(3,4);Bond, S.(5,6);Dowling, F.(5);Brezina, B.(1);Patel, K.(7);Ahmad, T.(8,9);Banim, P.(10);Cooney, R.(11);De La Revilla Negro, J.(1);de Silva , S.(12);Din, S.(13);Durai, D.(14);Gordon, J.(15);Irving, P.(16);Johnson, M.(17);Kent, A.(18);Kok, K.B.(19);Moran, G.(20);Patel, P.(21);Probert, C.(22,23);Raine, T.(1);Saich, R.(24);Seward, A.(7);Sharpstone, D.(25);Smith, M.(26);Subramanian, S.(1);Upponi, S.(27);Wiles, A.(28);van den Brink, G.(29,30);Vermeire, S.(31);Jairath, V.(32);D@E@Haens, G.(33);McKinney, E.(2,34,35);Lyons, P.(2,34,35);Lindsay, J.(19);Kennedy, N.(8);Smith, K.(2,34,35);Parkes, M.(1,2);
(1)Cambridge University Hospitals NHS Foundation Trust, Department of Gastroenterology, Cambridge, United Kingdom;(2)University of Cambridge School of Clinical Medicine, Department of Medicine, Cambridge, United Kingdom;(3)The Francis Crick Institute, Genetic Mechanisms of Disease Laboratory, London, United Kingdom;(4)Royal Free Hospital, Department of Gastroenterology- UCL Institute of Liver and Digestive Diseases, London, United Kingdom;(5)Cambridge University Hospitals NHS Foundation Trust, Cambridge Clinical Trials Unit, Cambridge, United Kingdom;(6)University of Cambridge, Medical Research Council Biostatistics Unit, Cambridge, United Kingdom;(7)St George’s Hospital, Department of Gastroenterology, London, United Kingdom;(8)Royal Devon University Healthcare NHS Foundation Trust, Department of Gastroenterology, Exeter, United Kingdom;(9)University of Exeter, Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, Exeter, United Kingdom;(10)James Paget University Hospital, Department of Gastroenterology, Great Yarmouth, United Kingdom;(11)University Hospitals Birmingham NHS Foundation Trust, GI Unit, Birmingham, United Kingdom;(12)Dudley Group NHS Foundation Trust, Department of Gastroenterology, Dudley, United Kingdom;(13)Western General Hospital, Edinburgh IBD Unit, Edinburgh, United Kingdom;(14)Cardiff and Vale University Health Board- University Hospital Wales, Department of Gastroenterology, Cardiff, United Kingdom;(15)Royal Hampshire County Hospital, Department of Gastroenterology, Winchester, United Kingdom;(16)Guy@E@s and St Thomas@E@ Foundation Trust, Department of Gastroenterology, London, United Kingdom;(17)Luton & Dunstable University Hospital, Department of Gastroenterology, Luton, United Kingdom;(18)King@E@s College Hospital NHS Foundation Trust, Department of Gastroenterology, London, United Kingdom;(19)Barts and The London NHS Trust, Department of Gastroenterology, London, United Kingdom;(20)University of Nottingham and Nottingham University Hospitals, National Institute of Health Research Nottingham Biomedical Research Centre, Nottingham, United Kingdom;(21)Epsom & St Helier University Hospitals, Department of Gastroenterology, Carshalton, United Kingdom;(22)Liverpool University Hospitals NHS Foundation Trust, Department of Gastroenterology, Liverpool, United Kingdom;(23)University of Liverpool, Department of Molecular and Clinical Cancer Medicine- Institute of Systems- Molecular and Integrative Biology, Liverpool, United Kingdom;(24)Basingstoke and North Hampshire Hospital, Department of Gastroenterology, Basingstoke, United Kingdom;(25)West Suffolk Hospital NHS Foundation Trust, Department of Gastroenterology, Bury St Edmunds, United Kingdom;(26)University Hospitals Sussex NHS Foundation Trust, Department of Gastroenterology, Brighton, United Kingdom;(27)Cambridge University Hospitals NHS Foundation Trust, Department of Radiology, Cambridge, United Kingdom;(28)The Queen Elizabeth Hospital King’s Lynn NHS Trust, Department of Gastroenterology, King’s Lynn, United Kingdom;(29)Amsterdam Gastroenterology and Metabolism- Tytgat Institute for Liver and Intestinal Research- Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, United Kingdom;(30)Roche, Roche Innovation Center Basel, Basel, Switzerland;(31)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(32)Western University, Division of Gastroenterology- Department of Medicine, London, Canada;(33)Amsterdam University Medical Centers, Department of Gastroenterology, Amsterdam, The Netherlands;(34)Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom;(35)PredictImmune Ltd, Babraham Research Campus, Cambridge, United Kingdom;
OP02: IL23R-CAR-Tregs: creating a therapeutic breakthrough for Crohn’s DiseaseECCO'24Year: 2024
Authors: Cui, Y.(1);Boulakirba, S.(2);David, M.(1);Bouchareychas, L.(1);Rouquier, S.(1);Sajuthi, S.(3);Ayrault, M.(1);Navarin, C.(1);Lafon, A.(1);Lara, G.(1);Menardi, A.(2);Saviane, G.(1);Dumont, C.(2);Abel, T.(1);Fenard, D.(1);Lu, H.(3);de la Rosa, M.(1);Gertner-Dardenne, J.(1)*;
(1)Sangamo Therapeutics, Research, Valbonne, France;(2)Sangamo Therapeutics, Non-clinical development, Valbonne, France;(3)Sangamo Therapeutics, Bioinformatics, Richmond, United States;
OP03: Efficacy and safety of the oral selective sphingosine-1-phosphate-1 receptor modulator VTX002 in moderately to severely active Ulcerative Colitis: results from a randomised, double-blind, placebo-controlled, phase 2 trialECCO'24Year: 2024
Authors: Sands, B.E.(1)*;Panaccione, R.(2);D@E@Haens, G.(3);Schreiber, S.(4);DuVall, A.(5);Kierkus, J.(6);Naik, S.(7);Gilder, K.(7);Yun, C.(7);Sandborn, W.J.(7);Walczak, M.(8);Vermeire, S.(9);Rubin, D.T.(10);Peyrin-Biroulet, L.(11,12,13);Danese, S.(14);
(1)Icahn School of Medicine at Mount Sinai Medical Center, Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States;(2)University of Calgary, Inflammatory Bowel Disease Unit- Division of Gastroenterology and Hepatology, Calgary, Canada;(3)Amsterdam University Medical Centers, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(4)University Hospital Schleswig-Holstein- Christian-Albrecht University of Kiel, Department of Internal Medicine I, Kiel, Germany;(5)Tyler Research Institute, Gastroenterology, Tyler, United States;(6)The Children’s Memorial Health Institute, Department of Gastroenterology- Hepatology- Nutritional Disorders and Pediatrics, Warsaw, Poland;(7)Ventyx Biosciences, Clinical Development, San Diego, United States;(8)Clinsante, Clinical Research Centre, Bydgoszcz, Poland;(9)University Hospitals Leuven, Department of Gastroenterology & Hepatology, Leuven, Belgium;(10)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States;(11)Nancy University Hospital, Department of Gastroenterology- INFINY Institute- FHU-CURE, Vandœuvre-lès-Nancy, France;(12)Groupe Hospitalier Privé Ambroise Paré – Hartmann, Paris IBD Center, Neuilly sur Seine, France;(13)University of Lorraine, INSERM- NGERE - Nutrition - Genetics and Exposure to Environmental Risks, Vandœuvre-lès-Nancy, France;(14)IRCCS Ospedale San Raffaele- Vita-Salute San Raffaele University, Gastroenterology and Endoscopy, Milan, Italy;N/A
OP04: Endoscopic healing in paediatric IBD perpetuates a persistent signature characterized by pathogenic Th17 cells and tissue-associated molecular and microbial drivers of diseaseECCO'24Year: 2024
Authors: Siebert, K.(1);Köhler, N.(2);Faro, T.(1);Matchado, M.(3);Hölz, H.(1);Jarosch, S.(4);Koletzko, S.(1);Ohnmacht, C.(5);List, M.(3);Busch, D.(4);Haller, D.(6);Schwerd, T.(1)*;
(1)LMU Klinikum, Dr. von Hauner Children’s Hospital- Department of Paediatrics, Munich, Germany;(2)Technical University of Munich, LipiTUM- Chair of Experimental Bioinformatics, Freising, Germany;(3)Technical University of Munich, Big Data in Biomedicine- Chair of Experimental Bioinformatics, Freising, Germany;(4)Technical University of Munich- Institute for Medical Microbiology, Immunology and Hygiene, Munich, Germany;(5)Technical University of Munich and Helmholtz Center Munich, Center of Allergy and Environment ZAUM- Research Center for Environmental Health, Neuherberg, Germany;(6)Technical University of Munich, Chair of Nutrition and Immunology- ZIEL-Institute for Food and Health, Freising, Germany;
OP05: Primary efficacy and safety of mirikizumab in moderate to severe Crohn’s Disease: results of the treat-through VIVID 1 studyECCO'24Year: 2024
Authors: Ferrante , M.(1)*;Danese , S.(2,3);Chen , M.(4);D@E@Haens , G.(5);Ghosh , S.(6);Hisamatsu , T.(7);Jairath , V.(8,9);Kierkus , J.(10);Peyrin-Biroulet , L.(11,12);Siegmund , B.(13);Bragg , S.M.(14);Crandall , W.(14);Hunter Gibble , T.(14);Lin , Z.(14);Ugolini Lopes , M.(14);Morris , N.(14);Carlier , H.(14);Sands , B.(15);
(1)University Hospitals Leuven- KU Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)University Vita-Salute San Raffaele, Gastroenterology and Gastrointestinal Endoscopy Unit, Milan, Italy;(3)IRCCS San Raffaele Hospital, Gastroenterology and Endoscopy, Milan, Italy;(4)First Affiliated Hospital of Sun Yat-Sen University, Division of Gastroenterology, Guangzhou- Guangdong, China;(5)Amsterdam University Medical Center, Inflammatory Bowel Disease Centre, Amsterdam, The Netherlands;(6)University College Cork, APC Microbiome Ireland Centre- College of Medicine and Health, Cork, Ireland;(7)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Tokyo, Japan;(8)University Hospital, Division of Gastroenterology- Department of Medicine, London- ON, Canada;(9)Western University, Division of Epidemiology and Biostatistics, London- ON, Canada;(10)The Children@E@s Memorial Health Institute, Department of Gastroenterology- Hepatology- Feeding Disorders and Pediatrics, Warsaw, Poland;(11)University of Lorraine- CHRU-Nancy, Department of Gastroenterology, Nancy, France;(12)University of Lorraine, Inserm- NGERE, Nancy, France;(13)Charité - Universitätsmedizin Berlin, Department of Gastroenterology- Infectious Diseases and Rheumatology, Berlin, Germany;(14)Eli Lilly and Company, Immunology, Indianapolis- IN, United States;(15)Icahn School of Medicine at Mount Sinai, Dr. Henry D. Janowitz Division of Gastroenterology, New York- NY, United States;VIVID Study Group
OP06: Risankizumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomised Phase 3 COMMAND StudyECCO'24Year: 2024
Authors: Louis , E.(1);Panaccione , R.(2);Parkes , G.(3);Peyrin-Biroulet , L.(4);Ferrante , M.(5);Hisamatsu , T.(6);Siegmund , B.(7);Kalabic , J.(8);Levine , P.(9);Neimark , E.(9);Wallace , K.(9);Chen , S.(9);Cheng , L.(9);Duan , W.R.(9);Armuzzi , A.(10);Biederman , L.(11);Loftus , E.(12);Melmed , G.(13);Schreiber , S.(14)*;
(1)University Hospital CHU of Liège, Hepato-Gastroenterology and Digestive Oncology Department, Liege, Belgium;(2)University of Calgary, Inflammatory Bowel Disease Unit- Division of Gastroenterology and Hepatology, Alberta, Canada;(3)Barts Health NHS Trust, Department of Gastroenterology, London, United Kingdom;(4)University Hospital of Nancy- Lorraine University, Department of Gastroenterology and INSERM U1256- NGERE- Faculty of Medicine, Vandoeuvre, France;(5)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(6)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Mitaka, Japan;(7)Charité-Universitätsmedizin Berlin- Humboldt-Universität zu Berlin and Berlin Institute of Health, Division of Gastroenterology- Infectiology and Rheumatology, Berlin, Germany;(8)AbbVie Deutschland GmbH & Co. KG, none, Ludwigshafen, Germany;(9)AbbVie, none, North Chicago, United States;(10)IRCCS Humanitas Research Hospital, IBD Center, Milan, Italy;(11)University Hospital Zurich, Zurich, Zurich, Switzerland;(12)Mayo Clinic College of Medicine and Science, Department of Gastroenterology and Hepatology, Rochester, United States;(13)F. Widjaja Foundation Inflammatory Bowel Disease Institute- Cedars Sinai Medical Center, none, Los Angeles, United States;(14)University Hospital Schleswig-Holstein- Christian Albrechts University, Department Internal Medicine, Kiel, Germany;
OP07: Consistent IBD treatment approaches across South Asian and White ethnicities despite phenotypic variations: a study of 33,157 patients using the IBD BioResourceECCO'24Year: 2024
Authors: Sharmili, B.(1,2)*;Martinez-Gili, L.(1);Alexander, J.(1,2);Mullish, B.(1,2);Perry, R.(1,2);Li, J.(1);Marchesi, J.(1);Parkes, M.(3);Orchard, T.(1,2);Hicks, L.(1,2);Williams, H.(1,2);
(1)Imperial College London, Metabolism- Digestion and Reproduction, London, United Kingdom;(2)Imperial College NHS Healthcare Trust, Gastroenterology and Hepatology, London, United Kingdom;(3)Cambridge University Hospitals NHS Foundation Trust, Gastroenterology and Hepatology, London, United Kingdom;
